JP5856725B2 - うつ病治療用または予防用医薬組成物 - Google Patents
うつ病治療用または予防用医薬組成物 Download PDFInfo
- Publication number
- JP5856725B2 JP5856725B2 JP2011169082A JP2011169082A JP5856725B2 JP 5856725 B2 JP5856725 B2 JP 5856725B2 JP 2011169082 A JP2011169082 A JP 2011169082A JP 2011169082 A JP2011169082 A JP 2011169082A JP 5856725 B2 JP5856725 B2 JP 5856725B2
- Authority
- JP
- Japan
- Prior art keywords
- earthworm
- depression
- pharmaceutical composition
- present
- dry powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011169082A JP5856725B2 (ja) | 2011-08-02 | 2011-08-02 | うつ病治療用または予防用医薬組成物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011169082A JP5856725B2 (ja) | 2011-08-02 | 2011-08-02 | うつ病治療用または予防用医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013032308A JP2013032308A (ja) | 2013-02-14 |
| JP2013032308A5 JP2013032308A5 (2) | 2014-09-04 |
| JP5856725B2 true JP5856725B2 (ja) | 2016-02-10 |
Family
ID=47788495
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011169082A Active JP5856725B2 (ja) | 2011-08-02 | 2011-08-02 | うつ病治療用または予防用医薬組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP5856725B2 (2) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10179120B2 (en) * | 2014-01-06 | 2019-01-15 | Iron Therapeutics Holdings Ag | Dosage regimen of ferric trimaltol |
| AU2015207191B2 (en) * | 2014-01-20 | 2020-03-26 | Well Stone Co. | Catecholamine production accelerator, and therapeutic and preventive agent and therapeutic and preventive food composition for diseases caused by catecholamine deficiency |
| GB201418710D0 (en) | 2014-10-21 | 2014-12-03 | Iron Therapeutics Holdings Ag | Dosage regimen |
| JP6321521B2 (ja) | 2014-11-04 | 2018-05-09 | Ｗｅｌｌ Ｓｔｏｎｅ 有限会社 | タウ蛋白産生促進剤、タウ蛋白の欠乏に起因する疾患の治療薬・予防薬および治療用・予防用食品組成物 |
| RU2696782C1 (ru) * | 2018-02-27 | 2019-08-06 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Ставропольский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО СтГМУ Минздрава России) | Способ купирования резистентных депрессивных синдромов психосоматического круга |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004292402A (ja) * | 2003-03-28 | 2004-10-21 | Mihara Lr Kenkyusho:Kk | ミミズ乾燥粉末の製造方法 |
| JP2007153802A (ja) * | 2005-12-05 | 2007-06-21 | Fujibio Co Ltd | 線溶活性を有するミミズ乾燥粉末及びその製造方法 |
| EP2514417A3 (en) * | 2007-05-07 | 2013-01-30 | Chelsea Therapeutics, Inc. | Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders |
-
2011
- 2011-08-02 JP JP2011169082A patent/JP5856725B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013032308A (ja) | 2013-02-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6985449B2 (ja) | 結節性硬化症の治療におけるカンナビジオールの使用 | |
| Jagadeesan et al. | Current trends in etiology, prognosis and therapeutic aspects of Parkinson’s disease: a review | |
| Didari et al. | Effectiveness of probiotics in irritable bowel syndrome: Updated systematic review with meta-analysis | |
| Newbury et al. | Malnutrition in older people: screening and management strategies | |
| AU2008292407B2 (en) | Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent | |
| JP5856725B2 (ja) | うつ病治療用または予防用医薬組成物 | |
| Shao et al. | Galanthamine, an acetylcholine inhibitor, prevents prepulse inhibition deficits induced by adolescent social isolation or MK-801 treatment | |
| CN106389740A (zh) | 一种预防和/或延缓老年轻度认知障碍的组合物及其使用方法 | |
| Lee et al. | Herbal medicine and acupuncture combined treatment attenuates colitis in rats | |
| Dashputre et al. | Overview of chronic diseases | |
| CN104095938A (zh) | 一种治疗抑郁症的蒙药制剂 | |
| Bembenek et al. | Fluoxetine for stroke recovery improvement–the doubleblind, randomised placebo-controlled FOCUS-Poland trial | |
| Song et al. | Mechanistic insights into the anti-depressant effect of quercetin: an integrated bibliometrics, bioinformatics, and animal experimentation | |
| KR101737775B1 (ko) | 통증 조절 및 탈수초 손상의 역전에서의 ｎ―2―하이드록시―에틸―피페라진―ｎ‘―2―에탄 설폰산（ｈｅｐｅｓ）의 역할 | |
| Roze et al. | Update on sleep disorders in advanced Parkinson’s disease: a narrative review | |
| Harris | Treating irritable bowel syndrome: A fresh and minty approach to an old therapy | |
| Lenka et al. | Sleep disturbances in patients with Parkinson’s disease: it’s time to wake up! | |
| TWI404542B (zh) | 用於治療抽動症及具有感覺運動門控不良之精神疾病的海州常山屬組合物 | |
| JP2008260728A (ja) | 線維筋痛症治療薬 | |
| CN107929666A (zh) | 一种治疗痴呆的中药组合物及其制备方法 | |
| US20210162047A1 (en) | A Drug For Treating Disorders Of An Organ Or Tissue Function And Diseases Accompanied By Such Disorders, And The Method For Obtaining It. | |
| Bolos et al. | S, tefanescu, G. Functional Gastrointestinal Disorders with Psychiatric Symptoms: Involvement of the Microbiome–Gut–Brain Axis in the Pathophysiology and Case Management. Microorganisms 2022, 10, 2199 | |
| RU2852910C2 (ru) | Применение композиции традиционной китайской медицины и лекарственного препарата для адъювантного лечения депрессии, способ адъювантного лечения депрессии | |
| CN104399060A (zh) | 金属硫蛋白复合制剂作为制备穴位介入治疗脑中风后遗症药物的应用 | |
| Malaspina et al. | Disorders of the Motor Cells: The Motor Neuron Diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140715 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140715 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150623 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20151208 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20151213 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 5856725 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |